Oxygenated Hemoglobin Wound Therapy System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional oxygen therapies for wound healing, such as hyperbaric oxygen therapy, face inefficiencies in oxygen absorption by wounds and red blood cells, leading to prolonged healing times due to excess positive pressure restricting blood flow and requiring time to restore pressure or oxygen after leaks.

Innovation Solution

The use of oxygenated hemoglobin, where oxygen is mixed with hemoglobin to form a mixture that is applied to wounds, leveraging hemoglobin's natural oxygen transport mechanism for more efficient oxygen delivery, reducing recovery times and improving wound healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional hyperbaric oxygen therapy is used to deliver oxygen to wounds, then oxygen therapy benefits are achieved, but oxygen absorption efficiency is low and healing time is prolonged

Engineering Contradiction:
Improvewound healing speedVSAvoidhealing time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent uses hemoglobin as an intermediary substance to transport oxygen to the wound site. Instead of delivering pure oxygen gas directly, the system mixes oxygen with hemoglobin (which has high oxygen affinity) to create an oxygen-hemoglobin mixture that can be efficiently absorbed by tissues, thereby accelerating wound healing and reducing treatment time.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the physical and chemical parameters of oxygen delivery by converting it from a gaseous state to a solution containing hemoglobin. This parameter change enables the oxygen to be delivered in a form that mimics natural blood oxygen transport, significantly improving absorption efficiency and reducing healing time.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If excess positive pressure is applied to maintain oxygen therapy, then oxygen delivery is maintained, but capillary blood flow is restricted

Engineering Contradiction:
Improveoxygen delivery consistencyVSAvoidcapillary restriction
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

Hemoglobin acts as a mediator that allows oxygen to be delivered at lower pressures. The hemoglobin-oxygen mixture can be administered without requiring excessive positive pressure, thus maintaining reliable oxygen delivery while avoiding capillary restriction and associated harmful effects.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If conventional oxygen therapy is used, then oxygen is provided to wounds, but oxygen absorption by red blood cells is inefficient

Engineering Contradiction:
Improveoxygen providedVSAvoidoxygen absorption efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent introduces hemoglobin as an intermediary that facilitates efficient oxygen absorption. Hemoglobin has a high affinity for oxygen and can bind and transport it effectively, allowing red blood cells at the wound site to absorb oxygen much more efficiently than from gaseous oxygen alone.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical form of oxygen from free gas to hemoglobin-bound oxygen, which fundamentally alters how oxygen is absorbed by tissues. This parameter change transforms an inefficient absorption process into an efficient one by leveraging hemoglobin's natural oxygen-carrying capabilities.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Oxygenated hemoglobin therapy enhances wound healing by efficiently delivering oxygen to wounds, reducing healing times and improving patient comfort through improved tissue growth and reduced recovery periods.

Implementation Method 1

oxygen is mixed with hemoglobin to form a mixture that is applied to wounds, leveraging hemoglobin's natural oxygen transport mechanism

Methodology Applied
Scientific EffectHemoglobin oxygen binding: Absorption (physical)

Data Source

PatentUS20220387224A1Oxygenated hemoglobin and apparatuses, systems, and methods therefore
Publication Date: 2022.12.08 3M INNOVATIVE PROPERTIES CO
  • US20220387224A1 patent drawing
  • US20220387224A1 patent drawing
  • US20220387224A1 patent drawing

AI summary

This disclosure describes devices, systems, and methods related to oxygenated hemoglobin, the generation thereof, and the use thereof. An exemplary oxygenated hemoglobin therapy system includes an oxygen source configured to provide oxygen and a hemoglobin source configured to provide topical hemoglobin. The therapy system may also include a mixer which has a first inlet, a second inlet, and an outlet. The mixer is configured to mix the oxygen and the topical hemoglobin to form a mixture and to provide the mixture to a dressing via the outlet. The therapy system may further include the dressing. The oxygenated hemoglobin therapy systems described herein are suitable for use in medical devices, such as bandages, drapes, dressings, and wound closures.